| Financial Year |
March 31 2023 |
| Monetary Funds |
16,720,883.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
162,881,259.67 |
| Advances to Suppliers |
32,378,383.13 |
| Other Receivables |
32,136,018.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
340,864.00 |
| Inventories |
191,025,603.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
74,622,926.55 |
| Total Current Assets |
517,875,364.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
560,875,685.63 |
| Under-construction Projects |
413,412,201.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
174,654,120.18 |
| R&D expenses |
-- |
| Goodwill |
370,579,600.36 |
| Long-Term Deferred and Prepaid Expenses |
1,195,133.20 |
| Deferred Income Tax Assets |
1,594,538.45 |
| Other Non-Current Assets |
8,053,031.11 |
| Sub-Total of Non-Current Assets |
1,616,704,170.50 |
| Total Assets |
2,134,579,534.76 |
| Short-Term Loans |
760,636,068.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
176,650,989.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,434,321.33 |
| Taxes Payable |
47,245,436.94 |
| Interest Payable |
343,830,696.97 |
| Dividend Payable |
-- |
| Other payables |
675,037,346.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,564,254.72 |
| Other Current Liabilities |
3,839,922.92 |
| Sub-Total of Current Liabilities |
1,868,256,802.13 |
| Long-term Loans |
571,877,404.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,931,743.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
67,290,298.60 |
| Deferred Income Tax Liabilities |
6,907,701.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
651,301,263.04 |
| Total Liabilities |
2,519,558,065.17 |
| Paid-In Capital(Or Share Stock) |
666,014,674.00 |
| Capital Surplus |
1,601,456,761.15 |
| Surplus Reserve |
88,230,286.24 |
| LESS:Treasury Stock |
38,367,000.00 |
| Undistributed Profits |
-2,247,146,910.45 |
| Minority Stockholder's Interest |
-441,605,829.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
56,627,299.35 |
| Owner's Equity（Stockholder's Equity） |
-384,978,530.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,134,579,534.76 |
